Lupin gets USFDA nod to launch generic tablet to treat overactive bladderStock in news: Lupin shares settled nearly 3% lower on Friday, quoting at ₹1,547 apiece on the NSE.
So far this year, Lupin stock price has surged nearly 18%, while the one-year gain on the stock is 120%.
Lupin gets USFDA nod to launch generic tablet to treat overactive bladder
Stock in news: Lupin shares settled nearly 3% lower on Friday, quoting at ₹1,547 apiece on the NSE. So far this year, Lupin stock price has surged nearly 18%, while the one-year gain on the stock is 120%.
